http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-119913-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb2c65fed767c6cdb08ca3b49dbb9f0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_457b7178efb5bb74cbdaa64d2772015c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d27794678ecff2bb2b743ccc9db723a
publicationDate 2022-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-119913-A1
titleOfInvention RIP1 INHIBITOR COMPOUNDS AND METHODS FOR MANUFACTURING AND USING THE SAME
abstract Kinase inhibitory compounds, such as receptor-interacting protein-1 (RIP1) kinase inhibitory compounds as well as pharmaceutical compositions and combinations comprising such inhibitory compounds are disclosed herein. The disclosed compounds, pharmaceutical compositions, and/or combinations can be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition. Claim 1: A compound, having a formula (1) or a pharmaceutically acceptable salt thereof, wherein: ring B is 5-membered or 6-membered heteroaryl wherein heteroaryl has (a) one, two or three atoms of nitrogen in the ring and the rest of the atoms in the ring are carbon; or (b) one or two nitrogen atoms and one oxygen atom with the proviso that R¹ is heterocyclyl, -C&
priorityDate 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5PXE9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID504727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID488195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID567460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID306886
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102152063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID306808

Total number of triples: 34.